Assyro AI

FDA Orange Book · active-ingredient family

Calcium chloride

Calcium chloride is approved as 1 brand and 7 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

1

Brand (NDA)

7

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINERRLDHOSPIRANDA 021117APJan 28, 2000

Generic (ANDA) products (7)

ProductApplicantApplicationTEApproved
CALCIUM CHLORIDE 10%SQUARE PHARMS PLCANDA 217463APSep 29, 2025
CALCIUM CHLORIDE 10%SOMERSETANDA 218133APDec 17, 2024
CALCIUM CHLORIDE 10%EXTROVISANDA 219342APNov 27, 2024
CALCIUM CHLORIDE 10%AMNEALANDA 217524APJul 08, 2024
CALCIUM CHLORIDE 10%MEDEFIL INCANDA 211553APMay 01, 2019
CALCIUM CHLORIDE 10%INTL MEDICATION SYSANDA 203477APMay 09, 2018
CALCIUM CHLORIDE 10%AM REGENTANDA 209088APJul 27, 2017

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Calcium chloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.